Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio (2016 - 2025)

Ironwood Pharmaceuticals' Asset Utilization Ratio history spans 15 years, with the latest figure at 0.75 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 21.31% year-over-year to 0.75; the TTM value through Dec 2025 reached 0.75, down 21.31%, while the annual FY2025 figure was 0.79, 7.37% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.75 at Ironwood Pharmaceuticals, down from 0.92 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.96 in Q3 2024 and bottomed at 0.37 in Q1 2023.
  • The 5-year median for Asset Utilization Ratio is 0.72 (2025), against an average of 0.67.
  • The largest annual shift saw Asset Utilization Ratio crashed 53.56% in 2021 before it skyrocketed 145.79% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.38 in 2021, then grew by 2.27% to 0.38 in 2022, then surged by 131.97% to 0.89 in 2023, then grew by 6.68% to 0.95 in 2024, then decreased by 21.31% to 0.75 in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Asset Utilization Ratio are 0.75 (Q4 2025), 0.92 (Q3 2025), and 0.92 (Q2 2025).